Regeneron's Axokine Story Continues; Subset Holds Hope
By Randall Osborne
Monday, April 7, 2003
"It's all Axokine," said analyst Steven Harr with Morgan Stanley in New York, earlier this month.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.